FCM
RXDX

Frontier Capital Management’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Frontier Capital Management’s Portfolio RXDX Stock Details RXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-66,282
Closed -$7.11M – 276
2023
Q1 		$7.11M Sell
66,282
-72,020
-52% -$7.73M 0.07% 212
2022
Q4 		$15.2M Buy
+138,302
New +$15.2M 0.17% 175